Poorer patients in US need greater access to cancer screening services
This article was originally published in Clinica
People in the US with no health insurance and those insured by Medicaid are more likely than those with commercial insurance to have cancer diagnosed at a late stage and efforts to improve access to cancer screening services are needed for these groups, US researchers report. Dr Richard Roetzheim of the University of South Florida and colleagues also found that race can affect the odds of a late-stage cancer diagnosis.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.